| |
|
|
|
Xtalks, online
2022 -11-10
The accelerated growth of patient-centric trials is driven by innovations in remote patient monitoring (RPM) and precision medicine. Insider intelligence estimates that 70.6 million US patients, or 26.2% of the population, will use RPM tools by 2025.
With this growth comes new potential, as sponsors and CROs gain the ability to drive better patient outcomes, increase patient adherence, improve health metrics, and ensure seamless patient onboarding.
However, it takes more than simply adding tools to your trial to gain this insight: Join us on Thursday, November 10, 2022 as experts from Medable’s Digital Medicine and Partner Technologies area showcase:
How digital data-flow designs, when mapped with clinical objectives, can support access to wider patient populations improving diversity & inclusion
How to increase operational efficiencies & enhance end-to-end patient enrollment, engagement, and retention
How first-hand experience in dermatology and oncology studies has identified robust patient populations which bring greater benefits to study outcomes
How the financial value of implementing DCTs can be realized in your organization
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Gillian Livock, SVP & GM Digital Endpoints, Medable Michael Howell, Ph.D., Chief Scientific Officer, DermTech Musaddiq (Muz) Khan, VP Therapeutic Area Solutions - Customer Value Team, Medable
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2022 -11-10
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|